Results 21 to 30 of about 612,298 (206)

Terbinafine-induced Toxic Epidermal Necrolysis in Pregnancy: A Case Report

Journal of Nepal Medical Association, 2023
Toxic epidermal necrolysis in pregnancy is a rare disease that can have an adverse effect on Toxic epidermal necrolysis in pregnancy is a rare disease that can have an adverse effect on pregnancy outcomes.
Ramesh Lamichhane, Mahendra Raj Pandey, Ayushma Dhungana, Anjana Lamsal   +3 more
doaj   +1 more source

Bronchiolitis obliterans associated with toxic epidermal necrolysis induced by infection: A case report and literature review

Frontiers in Pediatrics, 2023
BackgroundStevens-Johnson syndrome/toxic epidermal necrolysis has a severe impact on patients' eyes, genital mucosa, and many other organs. Bronchiolitis obliterans is a rare complication of Stevens-Johnson syndrome/toxic epidermal necrolysis.Data ...
Jingwei Liu, Haibo Yan, Chunfeng Yang, Yumei Li   +3 more
doaj   +1 more source

Lamotrigine, a Miscreant in Toxic Epidermal Necrolysis: A Rare Case Report [PDF]

, 2023
This case report is about a rural 39 years old female of Asian origin and laborer by profession who developed Toxic Epidermal Necrolysis (TEN) with lamotrigine.
Mahima MAKHIJA, Alka BANSAL, Deepak Raj SAKHNANI   +2 more
core   +2 more sources

Combination of cyclosporine A and methylprednisolone to treat pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome

Dermatology Reports, 2023
The treatment of epidermal necrolysis in pediatric patients remains a major challenge. Cyclosporine A has emerged as a promising therapy for epidermal necrolysis in adults; however, its efficacy in children is unclear.
Shinta Trilaksmi Dewi, Laily Noor Qomariah, Widya Khairunisa Sarkowi, Monika Puspitasari, Miya Khalidah, Marcella Anggatama, Dwinanda Almira Rizkiani, Kristiana Etnawati, Sri Awalia Febriana   +8 more
doaj   +1 more source

Toxic epidermal necrolysis [PDF]

F1000Research, 2016
Toxic epidermal necrolysis (TEN) is a rare, life-threatening drug-induced skin disease with a mortality rate of approximately 30%. The clinical hallmark of TEN is a marked skin detachment caused by extensive keratinocyte cell death associated with mucosal involvement. The exact pathogenic mechanism of TEN is still uncertain.
Hoetzenecker, Wolfram, Mehra, Tarun, Saulite, Ieva, Glatz, Martin, Schmid-Grendelmeier, Peter, Guenova, Emmanuella, Cozzio, Antonio, French, Lars E   +7 more
openaire   +4 more sources

Toxic epidermal necrolysis caused by flurazepam?

, 2005
Stevens-Johnson syndrome and toxic epidermal necrolysis are rare, but severe cutaneous reactions. Beside cutaneous manifestations, the syndrome is characterised by constitutional sypmtoms with even lethal consequences.
Bilusić, Marijo, Franić, Tomislav, Loncar, Caslav   +2 more
core   +4 more sources

Amoxicillin induced toxic epidermal necrolysis [PDF]

, 2020
Toxic epidermal necrolysis (TEN) is a rare life-threatening adverse drug reaction associated with mucocutaneous eruptions and peeling of skin (sloughing) mostly caused by drugs like sulphonamides, beta lactams, carbamazepine and non-steroidal anti ...
Narasimha G., Lakshmi, P., Kalpana
core   +2 more sources

Pembrolizumab-Induced Toxic Epidermal Necrolysis

Case Reports in Oncology, 2022
Immunotherapy has nowadays become part of the mainstay of treatment for several cancers. In this report, we present a case of toxic epidermal necrolysis (TEN) occurring as a relatively rare complication of pembrolizumab, which is a humanized monoclonal ...
Luca Borg, Malcolm Buhagiar, Elisa La Ferla, David Pisani, Janabel Said, Michael J. Boffa   +5 more
doaj   +1 more source

The application of comet assay in monitoring of the immunosuppression level in a patient with toxic epidermal necrolysis: A case report

Burns Open, 2017
Toxic epidermal necrolysis (TEN) represents the most serious affection within the SCARs group (Severe Cutaneous Adverse Reactions). It is an autoimmune disease manifested by extensive epidermal and mucosal exfoliation.
B. Lipový, M. Matejovičová, H. Řihová, D. Štikarovská, L. Novotná, M. Hlaváčová, H. Paulová, I. Suchánek, P. Brychta   +8 more
doaj   +1 more source

Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials [PDF]

Anais Brasileiros de Dermatologia, 2017
Lamotrigine is an antiepileptic drug used for the treatment of epilepsy, bipolar disorder and numerous off-label uses. The development of rash significantly affects its use. The most concerning of these adverse reactions is Stevens-Johnson syndrome/toxic
Romi Bloom, Kyle T. Amber
doaj   +2 more sources